IP Group was founded in 2001 and is listed on the main market of the LSE. It invests in companies underpinned by IP and scientific innovation, across HealthTech, DeepTech, CleanTech. Investments are sourced via partnerships with universities (including Oxford, Cambridge, Imperial and UCL), research institutions and other networks. The on-balance-sheet portfolio value is>£0.9bn, with >£0.5bn managed for 3rd parties. The portfolio has produced 4 unicorns and realised >£1.1bn.

02 Nov 2026

New venture growth mandate boosts fee prospects

IP Group has been appointed by Aberdeen Investments to manage a UK venture growth portfolio, via the CG Scottish Widows Growth LTAF. This is one of the first initiatives to actively allocate UK pension scheme members’ capital to UK venture growth - connecting patient institutional capital with British businesses of high potential.

It has announced that the first investments will be deployed across several strategically important areas of UK innovation, including quantum computing, advanced battery technology and AI-enabled healthcare.

CEO Greg Smith said: “We believe this is only the beginning of a much larger opportunity to unlock growth, support economic prosperity and deliver attractive long-term returns for savers.”

We retain our 111p fair value / share estimate but think this mandate should be a key contributor to fee income growth.

Download as a PDF file

Return to IP Group

Register to be first

Get research on the companies that interest you straight to your inbox

Equity Development is a partner to successful companies looking to enhance their investor relations. Our top-rated analysts produce best in class investment research. Based in London, UK, we help our clients connect with investors via presentations and interviews.

Equity Development Limited 3rd Floor, 80 Cheapside, London, EC2V 6EE

Website design & development by Breckenridge